References
- Hoeffken G, Meyer HP, Winter J, Verhoef L. CAP1 Study Group. The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia. Respir Med 2001;95:553–64.
- Malangoni MA, Song J, Herrington J, Choudhri S, Pertel P. Randomized controlled trial of moxifloxacin compared with piperacillin–tazobactam and amoxicillin–clavulanate for the treatment of complicated intra-abdominal infections. Ann Surg 2006;244:204–11.
- Schweiger ES, Weinberg JM. Novel antibacterial agents for skin and skin structure infections. J Am Acad Dermatol 2004;50:331–40.
- Bhatt V, Saleem A. Drug-induced neutropenia— pathophysiology, clinical features, and management. Ann Clin Lab Sci 2004;34:131–7.
- Torres A, Muir JF, Corris P, Kubin R, Duprat-Lomon I, Sagnier PP, et al. Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia. Eur Respir J 2003;21:135–43.
- Williams DP, Pirmohamed M, Naisbitt DJ, Uetrecht JP, Park BK. Induction of metabolism-dependent and independent neutrophil apoptosis by clozapine. Mol Pharmacol 2000;58:207–16.
- Akamizu T, Ozaki S, Hiratani H, Uesugi H, Sobajima J, Hataya Y, et al. Drug-induced neutropenia associated with anti-neutrophil cytoplasmic antibodies (ANCA): possible involvement of complement in granulocyte cytotoxicity. Clin Exp Immunol 2002;127:92–8.
- Salama A, Schütz B, Kiefel V, Breithaupt H, Mueller-Eckhardt C. Immune-mediated agranulocytosis related to drugs and their metabolites: mode of sensitization and heterogeneity of antibodies. Br J Haematol 1989;72:127–32.
- Mintzer DM, Billet SN, Chmielewski L. Drug-induced hematologic syndromes. Adv Hematol 2009;2009:495863.
- Chang CM, Lee NY, Lee HC, Lee IW, Wu CJ, Lin YS, et al. Moxifloxacin-associated neutropenia in a cirrhotic elderly woman with lower extremity cellulitis. Ann Pharmacother 2008;42:580–3.